Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05721287
Status:
RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-01-31
Brief Title:
A Phase 1 Randomized Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
Sponsor:
Sparian Biosciences Inc
Organization:
Sparian Biosciences Inc